Category Patents/Designs/Trade Secrets

European Council Approves First-Ever Analysis Of Drug Prices With Look At IP Rights

The 28 European Union governments today gave final approval to a first-ever plan to analyse medicines competition in Europe, with reference to drug prices, generics and biosimilars, and intellectual property rights. The final version was watered down after what sources said was heavy industry lobbying, compared to a leaked version published in Intellectual Property Watch two weeks ago, but still retains some strong provisions regarding pricing and competition.

Panels Brainstorm Ideas On Innovation And Drug Access

The quest of balance between encouraging medical innovation and the imperative of broad access to medicines has so far been elusive. Two Harvard University programmes jointly organised a workshop this week with the aim of encouraging a conversation between global health actors and see if some "outside the box" thinking is possible.

UN Development Agency Issues Guidelines For Pharmaceutical Patent Examiners

A new set of guidelines for pharmaceutical patent examination has been published by the United Nations Development Programme that seek to help reduce poor quality patents and ensure efficient market entry of generic products. The guidelines, written by a well-known advocate of access to medicines, aim at advising patent examiners in assessing the patentability requirements of applications relating to pharmaceutical products and processes.

More Changes In UN Agencies; Movements In Global Health

Movement has been happening in international organisations in recent weeks, particularly in United Nations agencies, as new executive directors were nominated, and department directorships changed hands. The private sector and non-governmental organisations also saw a number of position switches and nominations, in particular in the health sector. Law offices kept pace with the usual chair revolving.

New Ideas Coming For WTO TRIPS Council; But Also Old Debate Over EU Drug Seizures

The European Union presenting its new Trademark Directive during this week’s meeting of the World Trade Organization intellectual property council heard concerns of possible seizures of generic medicines transiting through Europe. Meanwhile, the new Council chair's attempts at revitalising discussions between member states received general approval. And a new agenda item on e-commerce was launched.